Seattle 2035 →
Co-Founder and CEO, DNAnexus
Co-Founder and CEO, Wetpaint
Executive Partner, Sofinnova Ventures
Managing director, the Foundry Group
VP of Venture Capital, Pfizer Inc.
CEO of Dynamis Corporation
Chairman, CEO, & Founder, Alexandria Real Estate Equities
CEO and Fund Manager, Renaissance Venture Capital Fund
September 30, 2015 ·
October 30, 2015 ·
Psylin Neurosciences is developing peptide-based drugs for psychological disorders.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.